Evgen Pharma Share Discussion Threads

[mdchand] 14/4/2020 09:41

Nobby - would be interesting to see if the share price movements forced them to release an RNS confirming your earlier comments.

[nobbygnome] 14/4/2020 09:07

So as usual the MMs are playing games. People are paying well above the offer for small amounts of shares....but they don't move the price up. Disgraceful...

[awise355] 14/4/2020 08:45

That's a bit rude

[langland] 14/4/2020 08:28

By coincidence I too, as an existing holder, have been researching sulforaphane this weekend as per my posts 1500 and 1501 and there does seem to be something to this. Technically, EVG looks as bombed out as SNG was at 6p and EVG has a gap to fill to 16 pence.

[nobbygnome] 14/4/2020 08:20

It seems to me that sulforaphane is the next drug which may be used in treating Covid 19 patients, which is very exciting. See below a paper which suggests this and another which shows that NRF-2 is a good target in inflammatory type situations such as seen in the lungs with Covid-19. Sulforaphane stimulates the NRF-2 pathway as one of its modes of action, which enables the pathway to exert it's anti inflammatory and anti oxidative functions.

So EVG must be having discussions along these lines and has to be a very interesting investment at this lowly level! All just IMHO and DYOR.....

[blakeysangel] 11/4/2020 12:36

Hi nobbygnome,
They took me off the stem Sfx01 because my scan in January showed an enlarged axillary lymph node , biopsy showed cancer, had them all removed in February, 10 nodes 5 positive, but 5 clear so the presumption is it hasn’t spread from there.I also had a rather unfortunate incident a few hours after my op where I was unresponsive for 40 mins(how to get the crash team and everyone else in a panic)so no more stem for me. But I’m all recovered now and so pleased with the NEAD scan....tough old bird that I am! 😀

[shortcpx] 11/4/2020 03:18

Smallcappick account. Obsessed with Detectortrader on Twitter

[nobbygnome] 10/4/2020 14:55

Good to hear! So why did they stop the sulforaphane if you weren't progressing?

[blakeysangel] 08/4/2020 18:19

Good grief some action on the board! Still got some shares here as I still believe it will come good. Had a difficult 3 months but had a no evidence of active disease scan 3 weeks ago 😀😀.

[langland] 08/4/2020 16:48

If you google sulforaphane and lung suppression, quite a bit of stuff comes up. I am not for 1 minute suggesting that it is a covid 19 treatment but ......

[langland] 08/4/2020 16:36

Except that somewhere I read that it may possibly aid in cases of lung suppression...whatever that is.

[langland] 08/4/2020 16:10

That's a thought, NG. You are the scientist you tell us!

[nobbygnome] 08/4/2020 16:07

I tend to agree with you there and I will look to buy here shortly as funds allow.

I wonder if sulforaphane has been looked at for an effect on Covid 19.....

[bones] 08/4/2020 15:56

This looks a decent punt at these prices. £5m market cap, an almost deserted bulletin board. What can go wrong?! In for a few at 4p.

[ohisay] 13/3/2020 13:19

Cheap as chips atm effectively trading at cash .
Bought 30k more at 4.37p.

[dave444] 20/2/2020 20:15

Think about it!The lowest price before the SAH negative result was 12p!Most bought in above 15p!Why would they sell at 4-5p?

[langland] 20/2/2020 14:18

There just doesn't seem to be any stock around at the moment. Mkt. makers seem to be short.....bidding well over the bid for 6 figure amounts.

[red rook] 19/2/2020 13:23

marketanalyst1,

... I'm well aware of 'monsieur' Griffiths buying here, as he has been doing in a number of other pharams ... however like Woodford he is not infallible. He takes a position in a number of companies ... and some will fail and some will succeed !

... I'm sure that the rest of the market is also aware of the 'potential positives' that you have pointed to above .... but it doesn't seem to have moved it.

[marketanalyst1] 19/2/2020 13:11

Red Rook, this is what happens when monsieur Griffiths builds a significant stake in a grossly undervalued micro cap:

[marketanalyst1] 19/2/2020 10:59

Red Rook, you're focussing on the wrong triggers.

Your first 'trigger' is Richard Griffiths. Get researching the chap. Understand his modus operandi and link it to the Evgen story. BOD changes and acquisitions of profoundly undervalued assets are a hallmark of his investing strategy.

But above all, the question you should be asking yourself is why Evgen? Why would an incredibly wealthy individual, worth £300m no less, be interested in Evgen? Once you're able to answer this, you'll be placing your next BUY order.

Your second 'trigger' is the £5m cash and Sulforadex. These two items are extremely attractive to external actors. Go and look up the Abzena story; I was invested there and it had all the valuation anomalies currently reflected in Evgen. Abzena had plenty of cash and a promising stable of drug candidates. It was valued at cash but acquired for 2x cash value.

Remember, a suitor may choose to deploy the cash for other activities once he's got his hands on it.

Your third and final 'trigger' is Evgen's current market cap of £5.3m. This is a gross undervaluation of the business. And as sure as night follows day, the market will correct this sooner rather than later.

Separately, and just to correct you. Evgen's cash is sufficient to QII 2021, so a pretty low cash burn and plenty of time for monetising the IP.

[red rook] 19/2/2020 10:36

marketanalyst1,

... At 15 February 2020, how much skin does the BOD (collectively) have in the company & when did they last buy any shares in the company ?

... When is the next trigger 'news flow' expected to give the shareprice a boost ... other than setting up more collaborations or more clinical trials ?

... Surely EVG's piddly 'cash pile', which is being used up as we blog, is not going to be a factor for any potential predators ?

... genuine questions